Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation : design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)